NO20032700D0 - Fremgangsmåte for fremstilling av alfa-1 proteinase inhibitor - Google Patents

Fremgangsmåte for fremstilling av alfa-1 proteinase inhibitor

Info

Publication number
NO20032700D0
NO20032700D0 NO20032700A NO20032700A NO20032700D0 NO 20032700 D0 NO20032700 D0 NO 20032700D0 NO 20032700 A NO20032700 A NO 20032700A NO 20032700 A NO20032700 A NO 20032700A NO 20032700 D0 NO20032700 D0 NO 20032700D0
Authority
NO
Norway
Prior art keywords
alpha
preparation
proteinase inhibitor
proteinase
inhibitor
Prior art date
Application number
NO20032700A
Other languages
English (en)
Other versions
NO20032700L (no
Inventor
Wytold Lebing
Mark D Chavez
David W Ownby
Susan Trukawinski
Woody D Wood
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21742222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032700(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20032700D0 publication Critical patent/NO20032700D0/no
Publication of NO20032700L publication Critical patent/NO20032700L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20032700A 2000-12-14 2003-06-13 Fremgangsmåte for fremstilling av alfa-1 proteinase inhibitor NO20032700L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/042811 WO2002048176A1 (en) 2000-12-14 2000-12-14 Method of preparing alpha-1 proteinase inhibitor

Publications (2)

Publication Number Publication Date
NO20032700D0 true NO20032700D0 (no) 2003-06-13
NO20032700L NO20032700L (no) 2003-07-17

Family

ID=21742222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032700A NO20032700L (no) 2000-12-14 2003-06-13 Fremgangsmåte for fremstilling av alfa-1 proteinase inhibitor

Country Status (9)

Country Link
EP (1) EP1343809B2 (no)
AU (1) AU2001245240A1 (no)
CA (1) CA2432641A1 (no)
ES (1) ES2543829T5 (no)
FI (1) FI1343809T4 (no)
NO (1) NO20032700L (no)
NZ (1) NZ526940A (no)
PT (1) PT1343809E (no)
WO (1) WO2002048176A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2543829T5 (es) 2000-12-14 2023-07-13 Grifols Therapeutics Inc Procedimiento para la preparación del inhibidor de proteinasa alfa 1
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
DE602004013021T3 (de) 2003-09-22 2012-04-05 Kamada Ltd. Herstellung eines alpha-1-proteinaseinhibitors im grossmassstab und dessen verwendung
NZ584766A (en) * 2007-11-02 2012-12-21 Grifols Therapeutics Inc Method, composition, and article of manufacture for providing alpha-1 antitrypsin
NZ590257A (en) * 2008-07-18 2012-08-31 Grifols Therapeutics Inc Method of preparing alpha-1 proteinase inhibitor
CN102180966B (zh) * 2011-01-28 2013-04-03 哈尔滨派斯菲科生物制药股份有限公司 一种规模化生产人α1-抗胰蛋白酶的方法
CA2837132A1 (en) * 2011-05-26 2012-11-29 Baxter International Inc. Solid phase-bound elastase-binding assay for the measurement of alpha1-antitrypsin activity
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
CN108026507A (zh) * 2015-04-02 2018-05-11 K·黄 由组分vi制造afod静脉注射剂的方法
WO2017078947A1 (en) * 2015-10-21 2017-05-11 Cambryn Biologics, Llc Processes for purifying proteins from plasma

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) 1942-02-09 1945-12-04 Research Corp Protein product and process
US4439358A (en) 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4379087A (en) 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4697003A (en) 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
US4749783A (en) 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5561064A (en) 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US5610825A (en) 1994-11-08 1997-03-11 Johnson; William J. Method and apparatus for the display of digitized analog signal loss
WO1997009350A1 (en) 1995-09-07 1997-03-13 Ppl Therapeutics (Scotland) Ltd. Purification of alpha-1 proteinase inhibitor
US5831003A (en) 1996-06-28 1998-11-03 Bayer Corporation Peptides which bind to prothrombin and thrombin
US5616693A (en) 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
US6093804A (en) 1998-09-24 2000-07-25 American National Red Cross Method for purification of alpha-1 proteinase inhibitor
US6462180B1 (en) 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
ES2543829T5 (es) 2000-12-14 2023-07-13 Grifols Therapeutics Inc Procedimiento para la preparación del inhibidor de proteinasa alfa 1

Also Published As

Publication number Publication date
NZ526940A (en) 2005-06-24
CA2432641A1 (en) 2002-06-20
EP1343809A4 (en) 2004-08-18
PT1343809E (pt) 2015-09-22
ES2543829T5 (es) 2023-07-13
AU2001245240A1 (en) 2002-06-24
FI1343809T4 (fi) 2023-09-04
EP1343809B1 (en) 2015-06-24
ES2543829T3 (es) 2015-08-24
NO20032700L (no) 2003-07-17
EP1343809B2 (en) 2023-03-15
EP1343809A1 (en) 2003-09-17
WO2002048176A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
DZ3318A1 (fr) Inhibiteur de proteinase
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
MXPA03003405A (es) Mezclas de alquido de quinona y compuestos de nitroxilo como inhibidores de polimerizacion.
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
AU2637801A (en) Methods of forming semiconductor structures
NO20020287L (no) Prodroge av en ICE-inhibitor
NO20016034D0 (no) Inhibitorer av aspartylprotease
NO20032048D0 (no) Fremgangsmåte for fremstilling av latent antitrombin III
NO20032700L (no) Fremgangsmåte for fremstilling av alfa-1 proteinase inhibitor
AU6141999A (en) Method for purification of alpha-1 proteinase inhibitor
IL156088A0 (en) Process for the isolation and purification of epothilones
AU2002233677A1 (en) Method of examining effect of angiogenesis inhibitor mediated by the inhibition of integrin expression
IL150806A0 (en) Piperidine-and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
NO20030699D0 (no) Fremgangsmåte for fremstilling av cilostazol
AU2001252884A1 (en) Method of dopamine inhibition using l-threo-methylphenidate
NO20004664D0 (no) FremgangsmÕte for fremstilling av HIV proteaseinhibitorer
AU2001292947A1 (en) Methods for inhibition of viral infection
EE200300116A (et) Efektiivne meetod faktori Xa inhibiitori valmistamiseks
AU2001251057A1 (en) Multi-domain proteinase inhibitor
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20005877A (no) Munnhygiene-preparat for hemning av halitose
NO20024887D0 (no) Fremgangsmåte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20011056D0 (no) FremgangsmÕte for utvelging av stivelse
NO20024957L (no) Inhibering av gulning i papir